# BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

> **NCT01744353** · PHASE1 · COMPLETED · sponsor: **Brown University** · enrollment: 35 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** Dose level 1
- **DRUG:** Dose level 2/MTD
- **DRUG:** Dose level 3

## Key facts

- **NCT ID:** NCT01744353
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-09
- **Final completion:** 2015-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744353, "BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01744353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*